Featured Speakers:
| Raghu Kalluri, Chair, Cancer Biology, MD Anderson Cancer Center | 
| Nicholas C. Dracopoli, Ph.D., Vice President, Janssen R&D, Johnson & Johnson |
| Marc Ladanyi, Chair, Molecular Oncology, Memorial Sloan-Kettering Cancer Center | 
| Michael E. Burczynski, Executive Director, Biomarker Technologies Bristol-Myers Squibb |
| Dennis J. Slamon, Chief, Hematology & Oncology, University of California, Los Angeles | 
| Kenneth Emancipator, M.D., Director, Companion Diagnostics, Merck Research Labs |
| Elaine Lyon, Ph.D., Medical Director, ARUP Laboratories | 
| Alan T. Wright, M.D., CMO, Roche Diagnostics Corporation |
| Darrell R. Borger, Director, Biomarker Laboratory, Harvard Medical School | 
| Monica Motwani, Ph.D., Director, Precision Medicine & Diagnostics, GlaxoSmithKline |
Tuesday, May 5, 6:00-9:00 pm
SC1: Fit-for-Purpose Biomarker Assay Development and Validation
John L. Allinson, FIBMS, Head, Biomarker Strategy, Drug Development Services, LGC Group
Viswanath Devanarayan, Ph.D., Global Head & Senior Research Fellow, Exploratory Statistics & Bioinformatics, AbbVie, Inc.
Wednesday, May 6, 6:00-9:00 pm
SC2: Next-Generation Sequencing as a Clinical Test
Seth Crosby, M.D., Director, Partnerships & Alliances, Washington University School of Medicine
Avni Santani, Ph.D., Assistant Professor, Clinical Pathology, University of Pennsylvania School of Medicine
*Separate Registration Required.
Key Contacts:
For meeting questions or suggestions:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
E: juliab@healthtech.com
For partnering and sponsorship information:
Ilana Quigley
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-5457
E: iquigley@healthtech.com
For media and association partnerships:
Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute
T: 781.972.5456
E: rhandy@healthtech.com